服薬アドヒアランス市場の2030年までの予測：タイプ別、薬物別、地域別の世界分析

Stratistics MRCによると、世界の服薬アドヒアランス市場は2023年に44億310万米ドルを占め、2030年には136億1,530万米ドルに達し、CAGRは17.5になると予測されています。

治療達成の重要な要素に服薬アドヒアランス、すなわち患者が推奨された処方レジメをどの程度守るかがあります。患者の服薬アドヒアランスの向上と追跡を目的として、様々な技術、治療法、サービスが市場に出回っています。医療プロバイダーと患者のコミュニケーションを改善し、最終的に患者が推奨された服薬ルーチンを確実に守るために、この分野のイノベーションにはウェアラブル技術、スマートピルディスペンサー、モバイルヘルスアプリ、患者教育プログラムなどがあります。

CMS.govの2022年12月の更新によると、2021年の国民医療費は2.7％増の4兆3,000億米ドル、1人当たり1万2,914米ドルとなり、米国の国内総生産（GDP）の18.3％を占めました。

規制への取り組み

服薬不遵守が医療の転帰と支出に大きな影響を及ぼすことは、世界の医療業界において政府や規制当局によってますます認識されるようになっています。これを受けて、服薬アドヒアランスプログラムの利用を促進するための法律やガイドラインが数多く施行されています。さらに、技術主導の服薬アドヒアランス・ツールの使用を奨励するガイドライン、服薬アドヒアランス技術を使用する医療専門家に対する支払いインセンティブ、服薬アドヒアランスの測定値を品質報告指標に組み込むことなどは、こうした取り組みのほんの一例に過ぎません。支援的な規制の枠組みは、最先端のアドヒアランス・サービスや技術の創造と応用を促進します。

標準化の欠如

標準化されたプロトコルやデータ形式がないため、技術的な接続性が阻害され、医療組織が統合的なアプローチを実施することが困難になっています。このような標準化の欠如は、包括的で相互運用可能なソリューションの構築を難しくするだけでなく、アドヒアランスへの介入の拡大性と有効性を制限します。しかし、医療専門家にとって、様々なアドヒアランス・技術からデータを収集し評価することは困難であり、洞察に満ちた推論を導き出し、カスタマイズ型治療を提供することをより困難にしています。

慢性疾患負担の増加

糖尿病、心臓病、呼吸器疾患などの疾病が一般的になるにつれ、疾病を効果的に管理するためには、個人が処方された通りに薬を使用し続けることが極めて重要になります。慢性疾患治療は複雑かつ長期にわたるため、患者が推奨される投薬スケジュールを遵守することは、問題を回避し全体的な健康を増進するために不可欠です。さらに、服薬コンプライアンスを支援・追跡する製品やサービスの革新は、アドヒアランス・ソリューションに対するニーズの高まりによって後押しされています。

服薬アドヒアランスソリューションのコスト

最先端の技術とデジタル・プラットフォームが処方コンプライアンスを強化する洗練された方法を提供しているにもかかわらず、これらのソリューションに関連する初期費用と継続的な費用は法外に高額になる可能性があります。医療の支払者、医療提供者、そして状況によっては患者も、このコスト問題の影響を受けます。リソースが限られている状況では、デジタルモニタリングシステムやスマートデバイスのようなアドヒアランス技術の導入と維持が、医療コストを圧迫する可能性があります。経済的な制約があるため、これらの治療法が広く採用されない可能性があり、その結果、様々な患者集団に対する有効性とアクセシビリティに影響を及ぼすことになります。

COVID-19影響

医療機関の閉鎖や医療システムの過負荷など、パンデミックの影響は、患者が処方された薬を処方通りに服用することがいかに重要であるかを強調しました。服薬アドヒアランスは、合併症を管理・予防する方法としてより重要になっています。さらに、パンデミックの急速な遠隔医療普及により、遠隔モニタリングや服薬アドヒアランス支援の機会が生まれています。

予測期間中、ソフトウェア中心のセグメントが最大となる見込み

ウェブプラットフォーム、モバイルアプリケーション、電子カルテ接続などのソフトウェアベースの介入に焦点を当て、ソフトウェア中心のカテゴリーが最大のシェアを占めると予測されます。これらのソフトウェアソリューションには、投与量追跡、リアルタイム・モニタリング、薬剤リマインダーなどの機能が頻繁に含まれています。さらに、患者と医療専門家のコミュニケーションを容易にし、カスタマイズ型アドヒアランス計画を可能にします。AI、ML、データ分析を統合し、特定の患者のニーズに合わせて介入をカスタマイズすることで、ソフトウェア中心のセクターは急激なイノベーションを経験しています。

予測期間中にCAGRが最も高くなると予想されるのはがん分野です。

がん治療中の患者の服薬アドヒアランス強化に重点が置かれていることから、腫瘍学セグメントは収益性の高い成長を遂げると予測されます。がん治療薬は非常に複雑で強力であるため、正確なコンプライアンスを維持することは治療成果を最大化するために不可欠です。これらのソリューションは、個別化された薬物治療、服用リマインダー、トレーニングリソースを提供することで、患者の理解と参加を向上させます。オンコロジーに重点を置いたアドヒアランス戦略は、患者が標的治療、化学療法、免疫療法のレジメを確実に実行できるようにすることで、投与漏れがもたらす可能性のある影響を軽減するように設計されています。

最もシェアの高い地域：

アジア太平洋は、医療インフラの発展、慢性疾患に対する意識の高まり、デジタルヘルスソリューションの利用拡大により、最大のシェアを占めると予想されます。慢性疾患の発生に対処するため、人口の規模や年齢を考慮した効果的な服薬アドヒアランス対策の必要性が高まっています。さらに、アジア太平洋市場の最近の開拓として、デジタルプラットフォームやモバイルアプリケーションを活用することで、患者のエンゲージメントとアドヒアランスを向上させるソフトウェア中心のソリューションの構築と利用が増加しています。

CAGRが最も高い地域：

医療への投資と政府の取り組みが拡大した結果、アジア太平洋は収益性の高い成長を遂げると予想されます。アジア太平洋の多様な医療情勢と独特の経済状況は、適応性と文化的感受性の高いアプローチを示しています。そのため、革新とカスタマイズは、この活気に満ちた急速に変化する地域の薬物療法導入市場特有の機会と課題に取り組むために不可欠です。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データ鉱業
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の服薬アドヒアランス市場：タイプ別

• イントロダクション
• ソフトウェア中心
• ハードウェア中心
  • 自動分注システム
  • 電子トレイ
  • スマート薬瓶
• その他のタイプ

第6章 世界の服薬アドヒアランス市場：薬剤別

• イントロダクション
• 筋骨格系
• 胃腸
• がん
• 糖尿病
• 中枢神経系
• 心臓血管
• リウマチ
• その他の薬

第7章 世界の服薬アドヒアランス市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東とアフリカ

第8章 主要発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイル

• Aardex Group
• AdhereTech Inc.,
• Caredose
• CareFusion（Becton Dickenson）
• DrFirst.com, Inc.
• ELucid MHealth
• Fruitech Ltd.
• Health Beacon
• HealthEra
• Johnson And Johnson Services Inc
• McKesson Corporation
• MedAdvisor International Pty Ltd
• PHC Holdings Corporation
• Propeller Health
• Proteus Digital Health

List of Tables

• Table 1 Global Medication Adherence Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 4 Global Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 5 Global Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 6 Global Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 7 Global Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 8 Global Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 9 Global Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 10 Global Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 11 Global Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 12 Global Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 13 Global Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 14 Global Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 15 Global Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 16 Global Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 17 Global Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
• Table 18 North America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
• Table 19 North America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 20 North America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 21 North America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 22 North America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 23 North America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 24 North America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 25 North America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 26 North America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 27 North America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 28 North America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 29 North America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 30 North America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 31 North America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 32 North America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 33 North America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 34 North America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
• Table 35 Europe Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
• Table 36 Europe Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 37 Europe Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 38 Europe Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 39 Europe Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 40 Europe Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 41 Europe Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 42 Europe Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 43 Europe Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 44 Europe Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 45 Europe Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 46 Europe Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 47 Europe Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 48 Europe Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 49 Europe Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 50 Europe Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 51 Europe Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
• Table 52 Asia Pacific Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
• Table 53 Asia Pacific Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 54 Asia Pacific Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 55 Asia Pacific Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 56 Asia Pacific Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 57 Asia Pacific Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 58 Asia Pacific Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 59 Asia Pacific Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 60 Asia Pacific Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 61 Asia Pacific Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 62 Asia Pacific Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 63 Asia Pacific Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 64 Asia Pacific Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 65 Asia Pacific Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 66 Asia Pacific Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 67 Asia Pacific Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 68 Asia Pacific Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
• Table 69 South America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
• Table 70 South America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 71 South America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 72 South America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 73 South America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 74 South America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 75 South America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 76 South America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 77 South America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 78 South America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 79 South America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 80 South America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 81 South America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 82 South America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 83 South America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 84 South America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 85 South America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
• Table 86 Middle East & Africa Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
• Table 87 Middle East & Africa Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
• Table 88 Middle East & Africa Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
• Table 89 Middle East & Africa Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
• Table 90 Middle East & Africa Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
• Table 91 Middle East & Africa Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
• Table 92 Middle East & Africa Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
• Table 93 Middle East & Africa Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
• Table 94 Middle East & Africa Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
• Table 95 Middle East & Africa Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
• Table 96 Middle East & Africa Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
• Table 97 Middle East & Africa Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
• Table 98 Middle East & Africa Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
• Table 99 Middle East & Africa Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 100 Middle East & Africa Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 101 Middle East & Africa Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
• Table 102 Middle East & Africa Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)

According to Stratistics MRC, the Global Medication Adherence Market is accounted for $4,403.1 million in 2023 and is expected to reach $13,615.3 million by 2030 growing at a CAGR of 17.5% during the forecast period. An important component of medical treatment accomplishment is medication adherence, or the extent to which patients adhere to their recommended prescription regimes. A variety of technologies, therapies, and services are available on the market with the aim of enhancing and tracking patient adherence to drug regimes. In order to improve communication between healthcare providers and patients and eventually ensure individuals follow their recommended medication routines, innovations in this sector include wearable technology, smart pill dispensers, mobile health apps, and patient education programs.

According to a CMS.gov December 2022 update, national health expenditure grew 2.7% to USD 4.3 trillion in 2021, or USD 12,914 per person, and accounted for 18.3% of the Gross Domestic Product (GDP) in the United States.

Market Dynamics:

Driver:

Regulatory initiatives

The substantial impact that medication non-adherence has on healthcare outcomes and expenditures is becoming increasingly recognized by governments and regulatory authorities in the healthcare industry globally. In response, a number of laws and guidelines have been put into effect to promote the use of medication adherence programs. Additionally, guidelines encouraging the use of technology-driven adherence tools, payment incentives for healthcare professionals using adherence techniques, and the incorporation of adherence measurements into quality reporting metrics are just a few instances of these initiatives. A supportive regulatory framework promotes the creation and application of cutting-edge adherence services and technologies.

Restraint:

Lack of standardization

The lack of standardized protocols and data formats impedes technology connectivity, making it challenging for healthcare organizations to implement an integrated approach. This lack of standardization restricts the scalability and effectiveness of adherence interventions, in addition to making the creation of comprehensive and interoperable solutions more difficult. However, it may be challenging for healthcare professionals to gather and assess data from various adherence technologies, which makes it more difficult to arrive at insightful inferences and deliver customized therapy.

Opportunity:

Rising chronic disease burden

As diseases like diabetes, heart problems, and respiratory disorders become more common, it is crucial that individuals keep using medications as prescribed in order to effectively manage illness. Because chronic therapies are complex and long-term, it is essential for patients to adhere to their recommended drug schedules in order to avoid issues and enhance their overall health. Moreover, innovation in products and services that support and track medication compliance is being fueled by the increased need for adherence solutions.

Threat:

Cost of adherence solutions

The upfront costs and continuous expenses associated with these solutions can be prohibitively expensive, even though cutting-edge technologies and digital platforms provide sophisticated ways to enhance prescription compliance. Healthcare payers, providers, and, in certain situations, patients are all affected by this cost issue. In contexts with limited resources, the implementation and maintenance of adherence technologies like digital monitoring systems and smart devices could put pressure on healthcare costs. Financial constraints may prevent these treatments from being widely adopted, which would affect their efficacy and accessibility for a range of patient populations.

COVID-19 Impact:

The pandemic's effects, including lockdowns and overloaded healthcare systems, emphasized how important it is for patients to take their prescriptions as prescribed. Medication adherence has become more important as a way to manage and prevent complications, as there is a greater understanding of the way the virus can have serious effects on those with chronic diseases. Additionally, the pandemic's rapid telehealth uptake has created opportunities for remote monitoring and adherence assistance.

The software centric segment is expected to be the largest during the forecast period

With a focus on software-based interventions such as web platforms, mobile applications, and electronic health record connections, the software-centric category is predicted to have the largest share. Patients have the ability to manage their treatment programs with the help of these software solutions, which frequently include features like dosage tracking, real-time monitoring, and drug reminders. Additionally, they also make it easier for patients and healthcare professionals to communicate, enabling customized adherence plans. With the integration of AI, ML, and data analytics to customize interventions to specific patient needs, the software-centric sector is experiencing exponential innovation.

The oncology segment is expected to have the highest CAGR during the forecast period

With an emphasis on enhancing drug adherence for patients undergoing cancer treatment, the oncology segment is predicted to experience profitable growth. Because oncology medicines are so complex and intense, maintaining precise compliance is essential to maximizing therapeutic outcomes. These solutions improve the patient's understanding and participation by offering individualized drug treatments, dose reminders, and training resources. Adherence strategies with an emphasis on oncology are designed to mitigate the possible effects of missed doses, making sure patients execute their targeted therapy, chemotherapy, or immunotherapy regimes.

Region with largest share:

Owing to the region's developing healthcare infrastructure, growing awareness of chronic illnesses, and growing use of digital health solutions, the Asia-Pacific area is anticipated to hold the largest percentage. In order to address the incidence of chronic illnesses, there is an increasing need for medication adherence measures that are effective considering the size and age of the population. Moreover, a recent development in the Asia-Pacific market is the increased creation and use of software-centric solutions that improve patient engagement and adherence by utilizing digital platforms and mobile applications.

Region with highest CAGR:

As a result of growing healthcare investments and government initiatives, the Asia-Pacific area is anticipated to have profitable growth. The Asia Pacific region's varied healthcare landscape and distinct economic circumstances indicate adaptable and culturally sensitive approaches, which is why innovation and customization are essential for tackling the particular opportunities and challenges within the medication adoption market in this vibrant and rapidly changing region.

Key players in the market:

Some of the key players in Medication Adherence market include Aardex Group, AdhereTech Inc., Caredose, CareFusion (Becton Dickenson), DrFirst.com, Inc., ELucid MHealth, Fruitech Ltd., Health Beacon, HealthEra, Johnson And Johnson Services Inc, McKesson Corporation, MedAdvisor International Pty Ltd, PHC Holdings Corporation, Propeller Health and Proteus Digital Health.

Key Developments:

In August 2022, Athenahealth added an automated patient engagement feature to help with medication adherence. The new release of the athenaOne EHR and practice management suite includes DrFirst's RxInform automated patient messaging to help patients follow prescribed treatment plans.

In January 2022, CareDxl expanded its medication adherence services with the acquisition of the Transplant Pharmacy. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers throughout the United States.

Types Covered:

• Software Centric
• Hardware Centric
• Other Types

Medications Covered:

• Musculoskeletal
• Gastrointestinal
• Oncology
• Diabetes
• Central Nervous System
• Cardiovascular
• Rheumatology
• Other Medications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Medication Adherence Market, By Type

• 5.1 Introduction
• 5.2 Software Centric
• 5.3 Hardware Centric
  • 5.3.1 Automated Dispensing Systems
  • 5.3.2 Electronic Trays
  • 5.3.3 Smart Pill Bottles
• 5.4 Other Types

6 Global Medication Adherence Market, By Medication

• 6.1 Introduction
• 6.2 Musculoskeletal
• 6.3 Gastrointestinal
• 6.4 Oncology
• 6.5 Diabetes
• 6.6 Central Nervous System
• 6.7 Cardiovascular
• 6.8 Rheumatology
• 6.9 Other Medications

7 Global Medication Adherence Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Aardex Group
• 9.2 AdhereTech Inc.,
• 9.3 Caredose
• 9.4 CareFusion (Becton Dickenson)
• 9.5 DrFirst.com, Inc.
• 9.6 ELucid MHealth
• 9.7 Fruitech Ltd.
• 9.8 Health Beacon
• 9.9 HealthEra
• 9.10 Johnson And Johnson Services Inc
• 9.11 McKesson Corporation
• 9.12 MedAdvisor International Pty Ltd
• 9.13 PHC Holdings Corporation
• 9.14 Propeller Health
• 9.15 Proteus Digital Health